UPDATE: StemCells Posts Wider Q4 Net Loss

reported a wider loss for the fourth quarter on Monday. The Newark, California-based company posted a quarterly net loss of $10,249,000, or $(0.15) per share, versus a year-ago net loss of $6,963,000, or $(0.13) per share. Excluding certain items, StemCells reported a non-GAAP loss of $(0.14) per share, compared to a loss of $(0.16) per share. Its total revenue from continuing operations climbed to $883,000, from $45,000 in the year-ago period. However, analysts were expecting a loss of $0.12 per share on revenue of $220.00 thousand. Its total operating expenses from continuing operations widened to $10,612,000 in the fourth quarter, from $9,341,000. At December 31, 2014, StemCells had $24,988,000 in cash and cash equivalents, an 18% drop versus December 31, 2013. StemCells shares rose 0.81% to $1.25 in the after-hours trading session.